1
|
Ersbøll J, Schultz HB. Non-Hodgkin's lymphomas: recent concepts in classification and treatment. Eur J Haematol Suppl 2009; 48:15-29. [PMID: 3073957 DOI: 10.1111/j.1600-0609.1989.tb01235.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
2
|
Thoufeeq MH, Ali Khan SL, Jain SK, Al-Shakerchi H, Hussain M. A case of acute infectious mononucleosis presenting with very high ferritin. World J Gastroenterol 2007; 13:637-8. [PMID: 17278235 PMCID: PMC4065991 DOI: 10.3748/wjg.v13.i4.637] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Hepatitis is an important but uncommon manifestation of acute Epstein Barr infection. Infectious mononucleosis is usually a disease of young adults. We report a case of infectious mononucleosis in a 72-year old jaundiced gentleman with ferritin level of 2438 that normalised on clinical improvement.
Collapse
|
3
|
Abstract
Immunodeficiency alters the risk of cancer. Specific types of immune dysfunction are associated with different tumor risks, but most tumors are related to oncogenic viruses. In acquired immunodeficiency due to the human immunodeficiency virus (HIV), HIV itself rarely directly causes cancer; rather, it provides the immunologic background against which other viruses can escape immune control and induce tumors. The most common malignancies are Kaposi's sarcoma and non-Hodgkin's lymphoma. This chapter discusses the pathophysiologic background of these tumors, how they have been affected by the use of anti-HIV medications, and their clinical management.
Collapse
Affiliation(s)
- David T Scadden
- AIDS Research Center and Cancer Center, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Room 5212, Boston, Massachussetts 02129, USA.
| |
Collapse
|
4
|
Abstract
The Epstein-Barr virus (EBV), one of eight known human herpesviruses, causes a wide spectrum of diseases under certain conditions. In particular, in the setting of immunodeficiency, which includes primary or secondary/acquired immunodeficiencies, they have been increasingly reported. The major clinical phenotype is the EBV genome-positive lymphoproliferative disorder, which ranges from benign lymphoproliferation to malignant lymphoma with cytogenetic alterations. Severe or fatal infectious mononucleosis may develop in some patients with immunodeficiencies such as X-linked lymphoproliferative disease.
Collapse
Affiliation(s)
- M Okano
- Department of Pediatrics, Hokkaido University School of Medicine, Sapporo, Japan.
| |
Collapse
|
5
|
Cohen K, Scadden DT. Non-Hodgkin's lymphoma: pathogenesis, clinical presentation, and treatment. Cancer Treat Res 2001; 104:201-30. [PMID: 11191128 DOI: 10.1007/978-1-4615-1601-9_7] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
MESH Headings
- Acquired Immunodeficiency Syndrome/complications
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Antiretroviral Therapy, Highly Active
- Antiviral Agents/therapeutic use
- Bleomycin/therapeutic use
- California
- Clinical Trials as Topic
- Combined Modality Therapy
- Cyclophosphamide/therapeutic use
- Dexamethasone/therapeutic use
- Doxorubicin/therapeutic use
- Herpesvirus 4, Human/isolation & purification
- Herpesvirus 8, Human/isolation & purification
- Homosexuality, Male
- Humans
- Infusions, Intravenous
- Lymphoma, B-Cell/pathology
- Lymphoma, Non-Hodgkin/complications
- Lymphoma, Non-Hodgkin/drug therapy
- Lymphoma, Non-Hodgkin/pathology
- Lymphoma, T-Cell/pathology
- Male
- Prognosis
- Registries
- Vincristine/therapeutic use
Collapse
Affiliation(s)
- K Cohen
- Massachusetts General Hospital, Dana-Farber/Harvard Cancer Center, Partners AIDS Research Center, Harvard Medical School, USA
| | | |
Collapse
|
6
|
Seo IS, Henley JD, Min KW, Yum MN. True histiocytic lymphoma of the esophagus in an HIV-positive patient: an ultrastructural study. Ultrastruct Pathol 1999; 23:333-9. [PMID: 10582271 DOI: 10.1080/019131299281482] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Abstract
A 56-year-old white woman, seropositive for human immunodeficiency virus for 18 months without signs of acquired immunodeficiency syndrome, presented with retrosternal pain and progressive dysphagia secondary to an exophytic esophageal mass. Biopsies of the tumor showed a malignant neoplasm composed of pleomorphic, noncohesive cells growing in a diffuse, sheet-like fashion. Immunohistochemically, tumor cells were nonreactive with epithelial, lymphoid, neural, and monocyte/macrophage markers. Despite the noncontributory immunohistochemical findings, ultrastructural study of the tumor cells revealed convincing histiocytic features. Individual cells possessed long, slender filopodial projections, prominent Golgi apparatus, residual bodies, rare lysosomes, and prelysosomes. Immunoglobulin heavy chain and T-cell receptor gamma gene rearrangement studies detected no evidence of a clonal gene rearrangement. The patient responded poorly to chemotherapy and died 5 months after her initial symptom of dysphagia.
Collapse
MESH Headings
- Antineoplastic Agents/therapeutic use
- Biomarkers, Tumor/analysis
- Esophageal Neoplasms/chemistry
- Esophageal Neoplasms/drug therapy
- Esophageal Neoplasms/ultrastructure
- Fatal Outcome
- Female
- HIV Infections/drug therapy
- HIV Infections/pathology
- HIV Seropositivity
- Humans
- Immunocompromised Host
- Immunoenzyme Techniques
- Lymphoma, AIDS-Related/chemistry
- Lymphoma, AIDS-Related/ultrastructure
- Lymphoma, Large B-Cell, Diffuse/chemistry
- Lymphoma, Large B-Cell, Diffuse/drug therapy
- Lymphoma, Large B-Cell, Diffuse/ultrastructure
- Microscopy, Electron
- Middle Aged
- Tomography, X-Ray Computed
- Zidovudine/therapeutic use
Collapse
Affiliation(s)
- I S Seo
- Department of Pathology, Wishard Memorial Hospital-Indiana University Medical Center, Indianapolis 46202, USA
| | | | | | | |
Collapse
|
7
|
Affiliation(s)
- I J Su
- Department of Pathology, National Cheng Kung University Medical College, Tainan
| | | |
Collapse
|
8
|
Abstract
The incidence of NHL is greatly increased in HIV-infected individuals. The vast majority are clinically aggressive B cell-derived neoplasms exhibiting BL, IBL, or LCL histology. Approximately 80% arise systemically (nodal and/or extranodal), and the remaining 20% arise as primary CNS lymphomas. A small proportion are body cavity-based lymphomas associated with KSHV infection. Possible factors contributing to lymphoma development include HIV-induced immunosuppression, chronic antigenic stimulation, and cytokine overproduction. These alterations are associated with the development of oligoclonal B-cell expansions. The appearance of NHL is characterized by the presence of a monoclonal B-cell population displaying a variety of genetic lesions, including EBV infection, c-myc gene rearrangement, bcl-6 gene rearrangement, ras gene mutations, and p53 mutations/deletions. The number and type of genetic lesions varies according to the anatomic site and histopathology. In the case of BL, virtually 100% exhibit c-myc gene rearrangements, two thirds display p53 gene mutations, one third contain EBV, and none exhibit bcl-6 gene rearrangements. In contrast, in the case of IBL, virtually 100% contain EBV, 25% display c-myc gene rearrangements, 20% display bcl-6 gene rearrangements, and very few exhibit p53 gene mutations. These findings suggest that more than one pathogenetic mechanism is operational in the development and progression of AIDS-related NHLs. Further work will be necessary to develop a complete understanding of the etiology and pathogenesis of NHL in the setting of HIV infection. AIDS-related NHL remains an important biologic model for investigating the development and progression of high-grade NHLs as well as NHLs that develop in immune-deficient hosts.
Collapse
MESH Headings
- B-Lymphocytes/physiology
- Cytokines/physiology
- Genes, Tumor Suppressor/physiology
- Growth Substances/physiology
- HIV/physiology
- Herpesvirus 4, Human/physiology
- Herpesvirus 8, Human/physiology
- Humans
- Lymphocyte Activation
- Lymphoma, AIDS-Related/epidemiology
- Lymphoma, AIDS-Related/etiology
- Lymphoma, AIDS-Related/pathology
- Lymphoma, AIDS-Related/virology
- Lymphoma, Non-Hodgkin/epidemiology
- Lymphoma, Non-Hodgkin/etiology
- Lymphoma, Non-Hodgkin/pathology
- Lymphoma, Non-Hodgkin/virology
- Proto-Oncogenes/physiology
- United States
Collapse
Affiliation(s)
- D M Knowles
- Department of Pathology, Cornell University Medical College, New York, New York, USA
| |
Collapse
|
9
|
Cheek BS, Hosford RG, Fulmer JM, Black ME. Lung Mass in an AIDS Patient. Proc (Bayl Univ Med Cent) 1996. [DOI: 10.1080/08998280.1996.11929973] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
10
|
Mathé G. Will killing the last HIV1 particle cure AIDS patients? Doesn't CMV activation and/or a graft-versus-host component of the disease, also have to be considered? I. First of two parts. Biomed Pharmacother 1996; 50:185-206. [PMID: 8949400 DOI: 10.1016/0753-3322(96)87659-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
Before the discovery of HIV1 and HIV2, I proposed as the mechanism of HIV1-AIDS complex, a graft versus host reaction (GvH) induced by transfusion or seringe or sexual act blood transferred lymphocytes: this was based on the clinical, pathological and biological, and especially immunological similarities. I have treated ten HIV1-AIDS complex patients in the last phase with five virostatics, distributed in three week sequence combinations of 3 or 4, each differing from the preceeding and following ones. After follow-up between one and three and a half years, the results can be summarized as such: when the viral loads fall below the detectable level, the CD8+ CD57+ suppressor T-cell and CD8+ CD57- cytotoxic T-cell numbers tend towards normal levels (approximately 200/mL), but the CD4 counts go up to a maximum of only 394, far from the normal level (800). Moreover, none of these subsets present a significant coefficient of correlation with the HIV1 load, which indicates that these immunologic markers and the viral one provide different information. I suggest the hypothesis according to which HIV1-AIDS complex comprises other components than HIV1 infection, such as a) the evoked GvH, which would occur early enough and might explain this CD4 incomplete restoration by virostatics, and b) cytomegalovirus (CMV) activation which occurs later. The second part of this editorial review will be published in a part II of the "Dossier" on AIDS. It will be devoted to the discussion of GvH and CMV infection systematic treatments.
Collapse
|
11
|
Ling SM, Roach M, Larson DA, Wara WM. Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Ten years of treatment experience at the University of California San Francisco. Cancer 1994; 73:2570-82. [PMID: 8174055 DOI: 10.1002/1097-0142(19940515)73:10<2570::aid-cncr2820731019>3.0.co;2-1] [Citation(s) in RCA: 65] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
BACKGROUND Classic human immunodeficiency virus (HIV) negative primary central nervous system lymphoma (PCNSL) is a relatively uncommon occurrence, whereas the incidence of HIV positive PCNSL has increased dramatically during the past 5 years. Between 2% and 6% of all patients with acquired immune deficiency syndrome (AIDS) will have PCNSL develop clinically, and as many as 11% will have PCNSL found at autopsy. In the United States, some of the earliest and most extensive experience with HIV positive PCNSL has occurred in San Francisco. This article reports on PCNSL in patients with and without HIV. METHODS Using our diagnosis-based computer retrieval system, we identified all patients treated with radiotherapy for PCNSL between January 1982 and January 1992 and reviewed their medical records. Population characteristics, risk factors and length of survival (LOS), were analyzed. Statistical methodology included the Cox proportional hazards model and Kaplan-Meier survival curves. RESULTS Fifty-six patients were identified with PCNSL, of which 41 were HIV positive and 15 were HIV negative. There was a fourfold increase in the total number of PCNSL cases during the time period 1987-1991 as compared with the preceding 5 years; these cases primarily were in the HIV positive group. The average Karnofsky performance score (KPS) in the HIV positive group was 50, whereas in the HIV negative group, the KPS was 35. However, the median LOS in the HIV positive group was 3 months, whereas in the HIV negative group it was 20 months. Within each group, there was a statistically significant correlation between KPS and LOS. CONCLUSIONS Patients with HIV and PCNSL have a much shorter median LOS than do patients with PCNSL but without HIV; however, the outcome for both groups is dismal. Randomized clinical trials are needed to determine which patients with HIV might benefit from more aggressive therapy and to determine the optimal choice and dosages of chemoradiation therapy for patients with PCNSL without HIV.
Collapse
Affiliation(s)
- S M Ling
- Department of Radiation Oncology, University of California San Francisco, San Francisco 94143
| | | | | | | |
Collapse
|
12
|
Cheng AL, Su IJ, Chen YC, Uen WC, Wang CH. Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma. Cancer 1993; 72:909-16. [PMID: 8101471 DOI: 10.1002/1097-0142(19930801)72:3<909::aid-cncr2820720341>3.0.co;2-o] [Citation(s) in RCA: 66] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
BACKGROUND The authors previously reported the existence of a unique subtype of peripheral T-cell lymphoma (PTCL) characterized by a clonotypical proliferation of Epstein-Barr virus (EBV) in the tumor cells (Blood 1991; 77:799). Detailed clinicopathologic features of this newly recognized entity remain to be clarified. METHODS A retrospective study was done in 23 patients receiving consecutive diagnoses at National Taiwan University Hospital by methods previously described. RESULTS There were 13 male and 10 female patients, with a median age of 40 years. Seventeen patients had Stage III/IV disease, and 15 patients had fever as a presenting B symptom. Initial extranodal involvement occurred in skin (10 patients), lung (4 patients), bone marrow (4 patients), brain (3 patients), and nasal cavity (1 patient) and was evidenced by hepatosplenomegaly (6 patients). Sixteen patients had specific histopathologic features including characteristics similar to angioimmunoblastic lymphadenopathy with dysproteinemia (3 patients), angioinvasive-type features (6 patients), Hodgkin disease-like features (2 patients), hepatosinusoidal-type features (2 patients), Lennert lymphoma (2 patients), and malignant histiocytosis-like features (1 patient). Six (37.5%) of the 16 patients who received a standard regimen with cyclophosphamide, doxorubicin, vincristine, and prednisone or an equivalent regimen as induction chemotherapy achieved complete remission. The median survival time was only 8 months. Six (42.8%) of the 14 patients who have died at this report ended up with a terminal hemophagocytosis syndrome. All five relapsed tumors were found to have a strong expression of P-glycoprotein (P-gp). CONCLUSIONS The authors suggest that EBV-associated PTCL should be regarded as a separate entity of non-Hodgkin lymphoma showing characteristic histopathologic features, frequent expression of P-gp in relapsed tumor, a terminal hemophagocytosis syndrome, and a generally ominous outcome.
Collapse
MESH Headings
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Adolescent
- Adult
- Aged
- Antibodies, Viral/blood
- Carrier Proteins/analysis
- Child
- Child, Preschool
- Female
- Herpesvirus 4, Human/immunology
- Histiocytosis, Non-Langerhans-Cell/etiology
- Histiocytosis, Non-Langerhans-Cell/mortality
- Humans
- Lymphoma, T-Cell, Peripheral/microbiology
- Lymphoma, T-Cell, Peripheral/pathology
- Lymphoma, T-Cell, Peripheral/physiopathology
- Male
- Membrane Glycoproteins/analysis
- Middle Aged
- Neoplasm Proteins/analysis
- Neoplasm Staging
- Retrospective Studies
- Survival Rate
- Tumor Virus Infections/immunology
- Tumor Virus Infections/pathology
Collapse
Affiliation(s)
- A L Cheng
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Republic of China
| | | | | | | | | |
Collapse
|
13
|
Dreno B, Milpied-Homsi B, Moreau P, Bureau B, Litoux P. Cutaneous anaplastic T-cell lymphoma in a patient with human immunodeficiency virus infection: detection of Epstein-Barr virus DNA. Br J Dermatol 1993; 129:77-81. [PMID: 8396410 DOI: 10.1111/j.1365-2133.1993.tb03316.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
The Epstein-Barr virus (EBV) genome exists in tumour cells of T-cell lymphomas in non-immunosuppressed patients. We identified EBV-DNA by in situ hybridization in a case of anaplastic T-cell lymphoma associated with acquired immunodeficiency syndrome (AIDS). EBV-DNA has been reported in AIDS-related Hodgkin's disease or B-cell lymphoma, but never in T-cell lymphoma. Although our results suggest that EBV could play a role in the development of these anaplastic T-cell lymphomas, the mechanism of EBV penetration into T-cells remains uncertain.
Collapse
Affiliation(s)
- B Dreno
- Department of Dermatology, Hôtel Dieu, Nantes, France
| | | | | | | | | |
Collapse
|
14
|
McGuire T. Chronic active Epstein-Barr virus infection, an AIDS-Co-Factor or predominant infection? Med Hypotheses 1993; 40:8-14. [PMID: 8384286 DOI: 10.1016/0306-9877(93)90189-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Chronic Active Epstein-Barr Virus is associated with Epstein-Barr Virus 2B (EBNA2B) and AIDS and possibly a widespread clinical syndrome. Provocative conclusions regarding their association are noted.
Collapse
|
15
|
Spitzer A, Weiss RA, Rapin I, Spiro AJ, Litman N, Ziprkowski MN, Horoupian D. Complications of immunosuppression. J Pediatr 1992; 121:145-53. [PMID: 1625073 DOI: 10.1016/s0022-3476(05)82564-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Affiliation(s)
- A Spitzer
- Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York 10461
| | | | | | | | | | | | | |
Collapse
|
16
|
Katz BZ, Berkman AB, Shapiro ED. Serologic evidence of active Epstein-Barr virus infection in Epstein-Barr virus-associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome. J Pediatr 1992; 120:228-32. [PMID: 1310507 DOI: 10.1016/s0022-3476(05)80432-9] [Citation(s) in RCA: 53] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The DNA and nuclear antigens of Epstein-Barr virus (EBV) have been detected in specimens of tissue of non-Hodgkin lymphoma and lymphocytic interstitial pneumonitis from patients with acquired immunodeficiency syndrome. To determine whether there is serologic evidence of an active EBV infection in these disorders, we conducted a case-control study. The case patients were 10 children with acquired immunodeficiency syndrome and EBV genome-positive pneumonitis or lymphoma. We randomly selected one or, if available, two matched control patients with human immunodeficiency virus infection for each index patient and compared their EBV serologic profiles with those of the index case patient at the time of the biopsy. Ten case patients and 13 matched control patients were enrolled. All 10 case patients (100%) compared with 2 (15%) of 13 matched control patients had serologic evidence of either a primary or a reactivated EBV infection at the time the index patient had a biopsy performed (p less than 0.001). Therefore we found serologic and virologic evidence that EBV is etiologically related to EBV-associated lymphocytic interstitial pneumonitis and non-Hodgkin lymphoma in children with acquired immunodeficiency syndrome.
Collapse
Affiliation(s)
- B Z Katz
- Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06510
| | | | | |
Collapse
|
17
|
Ramot B, Rechavi G. Non-Hodgkin's lymphomas and paraproteinaemias. BAILLIERE'S CLINICAL HAEMATOLOGY 1992; 5:81-99. [PMID: 1317730 DOI: 10.1016/s0950-3536(11)80036-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
18
|
Guarner J, del Rio C, Carr D, Hendrix LE, Eley JW, Unger ER. Non-Hodgkin's lymphomas in patients with human immunodeficiency virus infection. Presence of Epstein-Barr virus by in situ hybridization, clinical presentation, and follow-up. Cancer 1991; 68:2460-5. [PMID: 1657357 DOI: 10.1002/1097-0142(19911201)68:11<2460::aid-cncr2820681123>3.0.co;2-0] [Citation(s) in RCA: 25] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
The authors studied all patients with serologic evidence of human immunodeficiency virus (HIV) infection and malignant non-Hodgkin's lymphoma (NHL) that presented at a single hospital from 1982 to 1989. Sixteen patients were identified, all white homosexual men with a mean age of 38.2 years. Lymphoma was the initial presentation of HIV infection in 37.5%. Sixty-two percent of the cases had a high-grade NHL, 31% had intermediate-grade, and 6% (one patient) had a low-grade lymphoplasmacytoid lymphoma. Extranodal involvement was present in 43.7%, with the gastrointestinal tract and liver being the most common sites. Actuarial survival was increased by treatment with methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin (MACOP-B). Colorimetric in situ hybridization identified Epstein-Barr virus (EBV) in nine of the 14 cases hybridized. A statistically significant association of EBV with diffuse small noncleaved type (i.e., Burkitt's-like) (six of six) compared with other morphologic types (three of eight) was found (P = 0.025).
Collapse
Affiliation(s)
- J Guarner
- Department of Pathology, University School of Medicine, Atlanta, Georgia
| | | | | | | | | | | |
Collapse
|
19
|
Burns MK, Kennard CD, Dubin HV. Nodular cutaneous B-cell lymphoma of the scalp in the acquired immunodeficiency syndrome. J Am Acad Dermatol 1991; 25:933-6. [PMID: 1761773 DOI: 10.1016/0190-9622(91)70287-c] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Aggressive B-cell non-Hodgkin's lymphoma frequently complicates human immunodeficiency virus type 1 infection. Although extranodal disease is an important feature of this condition, the incidence of cutaneous involvement has not been determined. A review of 754 published cases of B-cell non-Hodgkin's lymphoma associated with human immunodeficiency virus type 1 revealed an incidence of cutaneous extranodal involvement of 8.2%, approximately equal to that seen in non-Hodgkin's lymphoma not associated with human immunodeficiency virus. Lymphoma was the initial manifestation of acquired immunodeficiency syndrome in two thirds of these cases. In particular, although the head and neck are commonly involved in non-Hodgkin's lymphoma not associated with human immunodeficiency virus, scalp involvement is uncommon in human immunodeficiency virus-associated B-cell non-Hodgkin's lymphoma, and we report the second case. The natural history and proposed pathogenesis of human immunodeficiency virus-associated non-Hodgkin's lymphoma are discussed.
Collapse
Affiliation(s)
- M K Burns
- Department of Dermatology, University of Michigan Medical Center, Ann Arbor 41809-0314
| | | | | |
Collapse
|
20
|
Pisani F, Antimi M, Cantonetti M, Marciani MG, Masi M, Tribalto M, Papa G. Non-Hodgkin lymphomas of the central nervous system. ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES 1991; 12:453-9. [PMID: 1955302 DOI: 10.1007/bf02335506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Non-Hodgkin lymphomas (NHL) of the Central Nervous System (CNS) are rare but they nonetheless constitute a clinical, biological and therapeutic problem of great interest. Primary lymphomas of the CNS account for 2% of all malignant lymphomas and for 0.3-1.5% of all intracranial tumors. Surgery and radiotherapy afford only poor control of the disease. The most satisfactory results have been achieved with combination therapy, surgery + radiotherapy + chemotherapy, but the optimal combination has still to be devised. Secondary neuromeningeal involvement affects a fair number of patients with systemic NHL. The symptoms are broadly the same as in CNS NHL and the treatment as problematic. There have recently been suggestions that the onset of CNS NHL may be exacerbated by immunodeficiency states such as occur in patients who have undergone organ transplantation, in autoimmune disease and, still more recently, in the acquired immunodeficiency syndrome (AIDS). The frequency of these tumors is anyway on the increase and a better insight into the disease in essential.
Collapse
Affiliation(s)
- F Pisani
- Cattedra di Ematologia, Università Tor Vergata, Roma
| | | | | | | | | | | | | |
Collapse
|
21
|
|
22
|
Ioachim HL, Dorsett B, Cronin W, Maya M, Wahl S. Acquired immunodeficiency syndrome-associated lymphomas: clinical, pathologic, immunologic, and viral characteristics of 111 cases. Hum Pathol 1991; 22:659-73. [PMID: 2071112 DOI: 10.1016/0046-8177(91)90288-z] [Citation(s) in RCA: 132] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The incidence of lymphomas in individuals infected with the human immunodeficiency virus has increased progressively since the beginning of the acquired immunodeficiency syndrome (AIDS) epidemic. The present series includes 111 patients, all diagnosed and studied at one hospital in New York City. There were 108 men and three women; the average age was 39 years and male homosexuality was the predominant risk factor. The materials examined originated from 138 surgical specimens and 24 autopsies. There were 11 cases of Hodgkin's lymphoma and 100 cases of non-Hodgkin's lymphomas (NHL), a proportion strongly skewed in favor of the latter. Hodgkin's lymphoma in AIDS patients was characterized by advanced clinical stage, high histologic grade, and frequent bone marrow involvement. Non-Hodgkin's lymphoma in AIDS patients, in contrast to the general population, originated predominantly in extranodal locations (61 cases) versus locations in which the lymph nodes were the site of the primary tumors (39 cases). In the digestive tract, the unusual oral and anal primary locations were often noted and were possibly related to specific risk factors. There were 15 cases of NHL of the central nervous system, an incidence 14 times greater than that recorded in the general population. The majority of NHLs were of high histologic grade, Burkitt's and large cell immunoblastic, representing most of the cerebral and gastrointestinal tumors. All NHLs were of B-cell immunophenotype. Lymphadenopathies with the histologic features of human immunodeficiency virus infection, particularly of the late stage (type C), often preceded NHL. Probing for Epstein-Barr virus genome was more frequently positive in Hodgkin's lymphoma than in NHL. Immunologic evaluations showed severely depressed T cell counts and CD4 to CD8 cell ratios as well as markedly increased levels of antilymphocyte antibodies. Reflecting the background of profound immune deficiency, the AIDS-associated lymphomas were characterized by high aggressiveness, early tendency to generalization, frequent post-treatment relapse, and short periods of survival.
Collapse
Affiliation(s)
- H L Ioachim
- Department of Pathology, Lenox Hill Hospital, New York, NY 10021
| | | | | | | | | |
Collapse
|
23
|
Henderson EE, Yang JY, Zhang RD, Bealer M. Altered HIV expression and EBV-induced transformation in coinfected PBLs and PBL subpopulations. Virology 1991; 182:186-98. [PMID: 1708929 DOI: 10.1016/0042-6822(91)90662-u] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Human immunodeficiency virus (HIV) IIIB expression and Epstein-Barr virus (EBV) B95.8-induced transformation were studied during coinfection. Coinfection of peripheral blood lymphocyte (PBL) cultures with HIV and EBV resulted in down-regulation of HIV expression. EBV-induced and spontaneous transformation were markedly reduced in PBL cultures exposed to HIV before EBV. On the other hand, transformation was enhanced when PBL cultures were infected with HIV either simultaneous to or after EBV. Reconstitution of EBV-infected B cell cultures with autochthonous T cells demonstrated that HIV-infected T cells had a reduced ability to inhibit EBV-induced transformation. PHA stimulation of HIV-infected T cells eliminated their ability to inhibit EBV-induced transformation. Lymphoblastoid cell lines (LCLs) established from coinfected PBLs expressed B cell markers and were EBV positive, while a large proportion of the LCLs expressed HIV antigens, released reverse transcriptase activity into the supernatant, and produced syncytia when cocultivated with indicator cell line SupT1. HIV provirus could be detected in LCLs established from coinfected cultures by PCR amplification using specific sets of amplimers for gag and env genes of HIV. To more closely examine the role of various cell types in lymphocyte transformation and HIV replication during coinfection, experiments were carried out using subpopulations enriched for either B or T cells. Simultaneous coinfection of purified B cells with EBV and HIV resulted in a marked reduction of HIV expression, whereas EBV-induced transformation was enhanced. In contrast, spontaneous B cell transformation was inhibited by HIV. A proportion of LCLs established from purified B cells coinfected with EBV and HIV expressed HIV antigens, released reverse transcriptase activity, and produced syncytia on SupT1 cells. These results demonstrate that the IIIB strain of HIV and B95.8 strain of EBV can interact during coinfection of B cells to alter the course of virus expression.
Collapse
Affiliation(s)
- E E Henderson
- Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140
| | | | | | | |
Collapse
|
24
|
Roithmann S, Toledano M, Tourani JM, Raphael M, Gentilini M, Gastaut JA, Armengaud M, Morlat P, Tilly H, Dupont B. HIV-associated non-Hodgkin's lymphomas: clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumors. Ann Oncol 1991; 2:289-95. [PMID: 1868025 DOI: 10.1093/oxfordjournals.annonc.a057938] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
From 1/87 to 12/89, the French Registry of HIV-associated tumors recorded 131 cases of intermediate- and high-grade non-Hodgkin's lymphomas (NHL). There were 47 small non-cleaved Burkitt-type lymphomas (SNCL), 32 immunoblastic lymphomas (IL) and 52 diffuse large-cell or predominantly large-cell lymphomas (LCL). There were differences in the clinical patterns of the histological subtypes. Isolated extranodal presentation was less frequent in SNCL (2/47) than in IL (13/32) and LCL (17/49) (p less than 0.0001). In the latter two groups, the central nervous system was the principal site of extranodal involvement (16/30), 87% of SNCL, patients had no previous manifestations of AIDS whereas 40% of IL and LCL patients presented full-blown AIDS (p less than 0.01). At the time of NHL diagnosis, the median blood CD4 lymphocyte count was higher in SNCL (266/microL) than in LCL (125/microL, p less than 0.05) and IL (80/microL, p less than 0.01), 69% of stages I/II patients, 31% of stages III/IV, and 33% of stage ie patients achieved complete remission (CR), p less than 0.05. Overall median survival time was 5 months. There was no statistical difference in CR and survival rates among histological types. The two-year actuarial survival rate was 25% (median 8 months) for initially asymptomatic patients or those with persistent generalized lymphadenopathy (PGL) and 9% (median 3 months) for those previously with AIDS-related complex (ARC) and AIDS patients (p less than 0.001). Response to treatment was the other predictor factor. The two-year survival rate was 42% (median 16 months) for patients who achieved CR, and 5% (median 3 months) for those who did not.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- S Roithmann
- Oncology-Hematology, Laennec Hospital, Paris
| | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Kornblau SM, Goodacre A, Cabanillas F. Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 new reports and a review of 148 cases from the literature. Hematol Oncol 1991; 9:63-78. [PMID: 1869243 DOI: 10.1002/hon.2900090202] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Tumour cell karyotypes from patients with Burkitt lymphoma (BL) or Burkitt's type leukemia (ALL3) were studied for correlation with survival, bone marrow and cerebral spinal fluid involvement (CSF), human immunodeficiency virus (HIV) serology, and for recurrent cytogenetic abnormalities. The records of 22 patients with BL from our institution and of 148 cases of BL and ALL3 reported in the literature with karyotypes were evaluated for clinical and cytological features. Overall survival was only 28 per cent and 88 per cent of deaths occurred within the first nine months after diagnosis. Those who survived at least 18 months were unlikely to relapse. Age and gender did not significantly affect survival. Patients presenting with advanced Ann Arbor stage, bone marrow or CSF involvement had lower survival rates. The association of translocations involving chromosome band 8q24 with this disease is confirmed. Sixty-two per cent of karyotypes had t(8;14)(q24;q32) translocations; the recognized variant translocations t(8;22)(q24;q11) and t(2;8)(p12;q24) affected 12 per cent and 9 per cent respectively. Seventeen per cent had abnormal karyotypes but no classic translocation. Patients with variant translocations had the poorest survival rates, and those with the classic t(8;14)(q24;q32) did the best. Despite a small sample size, the variant translocation t(8;22)(q24;q11) appeared to occur at an increased frequency in the patients with AIDS. In the entire group, recurrent involvement of chromosome regions 1q2, 6q11-14 and 17p1 suggests that alteration of genes at these loci, B Cell Growth Factor (BCGF) at 1q2 and p53 on 17p, may contribute to the development and progression of this tumour. Similarly, the frequent trisomies of chromosomes 7, 8, 12 and 18 may indicate an effect on tumour cell growth due to increased gene dosage. Trisomy 12 was found in eight tumours, five from patients with AIDS, suggesting that chromosome 12 has a site or gene whose allelic dosage is selected for in AIDS related lymphoma cells. Cytogenetic studies of adult Burkitt lymphoma and leukemia suggest several likely loci for gene alterations that in conjunction with myc translocations can lead to tumorigenesis.
Collapse
Affiliation(s)
- S M Kornblau
- Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030
| | | | | |
Collapse
|
26
|
Brada M. Impact of molecular biology on our understanding of non-Hodgkin lymphoma. Eur J Cancer 1991; 27:315-20. [PMID: 1827324 DOI: 10.1016/0277-5379(91)90537-n] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- M Brada
- Institute of Cancer Research and Royal Marsden Hospital, U.K
| |
Collapse
|
27
|
Diebold J, Audouin J, Le Tourneau A, Prevot S, Szekeres G. Lymph node reaction patterns in patients with AIDS or AIDS-related complex. CURRENT TOPICS IN PATHOLOGY. ERGEBNISSE DER PATHOLOGIE 1991; 84 ( Pt 2):189-221. [PMID: 2044409 DOI: 10.1007/978-3-642-75522-4_6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
28
|
Gold JE, Ghali V, Gold S, Brown JC, Zalusky R. Angiocentric immunoproliferative lesion/T-cell non-Hodgkin's lymphoma and the acquired immune deficiency syndrome: a case report and review of the literature. Cancer 1990; 66:2407-13. [PMID: 2245397 DOI: 10.1002/1097-0142(19901201)66:11<2407::aid-cncr2820661127>3.0.co;2-n] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The lesions known as lymphocytic vasculitis, polymorphic reticulosis (midline malignant reticulosis, lethal midline granuloma), lymphomatoid granulomatosis, and angiocentric lymphoma form what have been collectively termed the angiocentric immunoproliferative lesions (AIL). Because of recent reports demonstrating clonal rearrangements of the T-cell receptor in these lesions, the AIL are now thought to represent a continuous spectrum of post-thymic T-cell non-Hodgkin's lymphoma (NHL). NHL associated with the acquired immune deficiency syndrome (AIDS) represents intermediate or high-grade B-cell malignancies in HIV-infected patients that may be etiologically related to the Epstein-Barr virus (EBV). There have been reports of EBV-associated T-cell NHL, AIL, and large granular lymphocyte (LGL) proliferations, as well as HIV-associated T-cell neoplasia, LGL/T-cell proliferations, and AIL. We describe a case of polymorphic reticulosis (lethal midline granuloma) arising in an HIV-infected individual, who later progressed to AIDS, and review the literature on HIV-associated and EBV-associated T-cell neoplasia, LGL/T-cell proliferations, and AIL. The etiology of this AIL/T-cell NHL, especially in relation to EBV and HIV, is discussed.
Collapse
Affiliation(s)
- J E Gold
- Department of Medicine, Beth Israel Medical Center, Mount Sinai School of Medicine, New York, N.Y. 10003
| | | | | | | | | |
Collapse
|
29
|
Telenti A, Marshall WF, Smith TF. Detection of Epstein-Barr virus by polymerase chain reaction. J Clin Microbiol 1990; 28:2187-90. [PMID: 2172284 PMCID: PMC268144 DOI: 10.1128/jcm.28.10.2187-2190.1990] [Citation(s) in RCA: 90] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
The polymerase chain reaction (PCR) was used to study DNA extracted from the blood of 25 transplant patients, 5 patients with infectious mononucleosis, and 13 healthy subjects and autopsy or biopsy tissue from 29 patients with lymphoproliferative disorders. Primers were directed to conserved regions of the Epstein-Barr virus (EBV) genome encoding capsid protein gp220 and Epstein-Barr nuclear antigen 1. Specific EBV amplification was found in the blood of 11 of 25 transplant patients and all patients with infectious mononucleosis. All patients with lymphoproliferative disorders occurring in the presence of immunosuppression (eight organ transplant patients and two patients with acquired immunodeficiency syndrome) had biopsies positive for EBV by PCR. Only 1 of 19 samples from lymphomas or leukemias unrelated to immunosuppression contained EBV. PCR confirmed the very close association of EBV and lymphoproliferative disorders occurring in the presence of immunosuppression. The significance of detecting EBV sequences in the blood of transplant patients, particularly in relationship to lymphoproliferation, requires further study.
Collapse
Affiliation(s)
- A Telenti
- Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota 55905
| | | | | |
Collapse
|
30
|
Abstract
The immunodeficient state that evolves in persons infected with the human immunodeficiency virus (HIV) appears to increase their risk of certain types of cancer. Among these are primary lymphoma of the central nervous system, undifferentiated non-Hodgkin's lymphoma, squamous cell carcinoma, anorectal carcinoma, and cutaneous malignancies. These malignancies are similar in incidence to those seen in other immunodeficient patients. Lymphoma, in particular, is associated with a more aggressive disease state. In HIV-infected patients, the disease is usually diagnosed at a more advanced stage, frequently has extranodal involvement, and usually responds poorly to chemotherapy. Viruses, such as Epstein-Barr virus and papillomavirus, have been implicated in the pathogenesis of lymphoma and other malignancies in immunosuppressed patients, including those with HIV infection.
Collapse
Affiliation(s)
- P L Myskowski
- Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
| | | | | |
Collapse
|
31
|
Friedman SL. Kaposi's sarcoma and lymphoma of the gut in AIDS. BAILLIERE'S CLINICAL GASTROENTEROLOGY 1990; 4:455-75. [PMID: 2282386 DOI: 10.1016/0950-3528(90)90012-6] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
KS and non-Hodgkin's lymphomas frequently involve the gut in patients with AIDS. These neoplasms establish the diagnosis of AIDS in an HIV-positive patient. KS is a spindle-cell tumour derived from lymphatic endothelia which is associated with luminal lesions in at least 40% of patients. Gastrointestinal KS is usually asymptomatic but may rarely bleed or obstruct. Treatment of KS with either interferon-alpha, radiation or chemotherapy can reduce tumour bulk, but does not alter overall survival in AIDS. Non-Hodgkin's lymphomas in AIDS are B cell neoplasms with many genotypic and phenotypic similarities to Burkitt's lymphoma. The tumours are usually highly aggressive, and present in extranodal sites in the majority of cases. Of these extranodal sites, gastrointestinal involvement is most common. Gastrointestinal lymphomas are usually symptomatic and almost always require treatment. Obstruction, perforation and bleeding may occur in patients with luminal involvement, whereas hepatic or biliary disease may lead to jaundice. Several chemotherapeutic regimens for lymphoma have been successfully used to achieve partial remission, although no prolongation of survival has been demonstrated. There appears to be an increased incidence of Hodgkin's disease in patients with AIDS, which is generally of advanced stage. This tumour does not meet the CDC criteria for AIDS as yet. Hepatic and/or splenic involvement in this setting are common.
Collapse
|
32
|
Francis N. Light and electron microscopic appearances of pathological changes in HIV gut infection. BAILLIERE'S CLINICAL GASTROENTEROLOGY 1990; 4:495-527. [PMID: 2282387 DOI: 10.1016/0950-3528(90)90014-8] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
33
|
Rupniak NM, Tye SJ, Steventon MJ, Boyce S, Iversen SD. Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: implications for tardive dyskinesia. Mov Disord 1990; 5:314-8. [PMID: 2259355 DOI: 10.1002/mds.870050410] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
We describe a syndrome of spontaneous orofacial dyskinesias and cage stereotypies in a singly housed adult cynomolgus monkey never previously exposed to neuroleptic drugs. Abnormal movements were readily suppressed by acute treatment with haloperidol (0.03-0.24 mg/kg i.m.) or SCH23390 (0.05-0.2 mg/kg i.m.) but not by physostigmine (0.005-0.04 mg/kg i.m.) or scopolamine (0.0025-0.04 mg/kg i.m.). The symptomatology and response to pharmacological manipulations was indistinguishable from that previously attributed to chronic neuroleptic treatment in primates. Our findings indicate that neuroleptic-induced tardive dyskinesias in most primate studies have not been clearly demonstrated.
Collapse
Affiliation(s)
- N M Rupniak
- Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, England
| | | | | | | | | |
Collapse
|
34
|
Osato T, Imai S, Kinoshita T, Aya T, Sugiura M, Koizumi S, Mizuno F. Epstein-Barr virus, Burkitt's lymphoma, and an African tumor promoter. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 1990; 278:147-50. [PMID: 1963031 DOI: 10.1007/978-1-4684-5853-4_15] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- T Osato
- Department of Virology, Hokkaido University School of Medicine, Sapporo
| | | | | | | | | | | | | |
Collapse
|
35
|
Doll DC, Ringenberg QS. Lymphomas associated with HIV infection. Semin Oncol Nurs 1989; 5:255-62. [PMID: 2682879 DOI: 10.1016/0749-2081(89)90006-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
|
36
|
Purtilo DT, Grierson HL, Ochs H, Skare J. Detection of X-linked lymphoproliferative disease using molecular and immunovirologic markers. Am J Med 1989; 87:421-4. [PMID: 2572169 DOI: 10.1016/s0002-9343(89)80825-3] [Citation(s) in RCA: 27] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
PURPOSE, PATIENTS, AND METHODS Detection of males affected with the X-linked lymphoproliferative disease (XLP) was sought using immunovirologic and molecular genetic linkage techniques. The study population consisted of 20 males in six families with XLP. RESULTS Concordance for detection of affected males was 100% when linkage analysis using DXS42 and DXS37 DNA probes and antibody responses to challenge with bacteriophage phi X174 were both determined. Most affected males showing IgG subclass immune deficiency could not produce antibodies to Epstein-Barr virus nuclear antigen and had deficient responses to challenge with bacteriophage phi X174. CONCLUSION Use of only one of the techniques described can fail to lead to the diagnosis of XLP, because problems can prevail with each individual determination.
Collapse
Affiliation(s)
- D T Purtilo
- Department of Pathology, University of Nebraska Medical Center, Omaha 68105-1065
| | | | | | | |
Collapse
|
37
|
Hamilton-Dutoit SJ, Pallesen G, Karkov J, Skinhøj P, Franzmann MB, Pedersen C. Identification of EBV-DNA in tumour cells of AIDS-related lymphomas by in-situ hybridisation. Lancet 1989; 1:554-2. [PMID: 2564083 DOI: 10.1016/s0140-6736(89)90093-7] [Citation(s) in RCA: 64] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
38
|
Roncella S, Caretto P, Forni G, Cutrona G, Verde A, Ramarli D, di Celle PF, Foà R, Sessarego M, Pistoia V. Studies on the oncogenic potential of Epstein-Barr-virus (EBV)-infected B cells in AIDS-related disorders. INTERNATIONAL JOURNAL OF CANCER. SUPPLEMENT = JOURNAL INTERNATIONAL DU CANCER. SUPPLEMENT 1989; 4:78-82. [PMID: 2553627 DOI: 10.1002/ijc.2910440721] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Spontaneous lymphoblastoid cell lines (LCLs) were established from the peripheral blood of 10 human immunodeficiency virus (HIV)-seropositive patients in order to investigate whether or not progression of the cells towards a malignant state could be traced. The LCLs studied displayed no differences in their surface phenotype, karyotype, and tumorigenicity in nude mice as compared with a wide panel of control LCLs. Furthermore, no c-myc rearrangement could be detected in any of the LCLs. However, 4 of the 10 LCLs derived from HIV-seropositive patients formed colonies in agar with a cloning efficiency of 0.1-0.9%. This percentage was much lower than that of a control neoplastic B cell line (50%), but consistently higher than that observed for a battery of spontaneous LCLs. The cells of a number of sublines that were derived from the agar colonies expressed new activation markers (CD10 and Bac-1) but did not induce tumors in nude mice or display chromosomal abnormalities. These sublines might comprise cells that have progressed towards a more markedly transformed state.
Collapse
Affiliation(s)
- S Roncella
- Servizio di Immunologia Clinica, Istituto Nazionale per la Ricerca sul Cancro, IST Genoa, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
|
40
|
|
41
|
|
42
|
Abstract
The clinical features and laboratory results of 63 patients with or at risk for AIDS with lymphoid neoplasias seen from November 1980 through November 1986 are reviewed. Forty-three had systemic non-Hodgkin's lymphoma (NHL), nine had primary large cell lymphomas of the brain, 11 had Hodgkin's disease (HD), and one had plasmacytoma evolving to myeloma. Those with systemic NHL included 40 (93%) with intermediate or high-grade histologies, 35 (81%) with advanced stage (III, IV), and 28 (65%) with extranodal disease at presentation (predominantly marrow and meninges). Overall survival was short (median, 10.5 months from diagnosis) with the majority of deaths attributable to AIDS-related opportunistic infections (OI). However, 17 patients with diffuse NHL achieved a complete clinical remission, and nine now have been disease-free for more than 1 year (median follow-up, 28 months; range, 12 to 73 months). Early stage and lack of systemic symptoms were features associated with prolonged disease-free survival. Primary brain NHL was a uniformly lethal manifestation of AIDS, being diagnosed at postmortem in seven of nine severely immunosuppressed homosexual men. As with NHL, a propensity towards advanced disease and extranodal involvement was also observed in HD, suggesting that the atypical clinical behavior of HD may be an additional epiphenomenon of AIDS. This experience tends to argue for the use of intensive therapy in at least some patients with AIDS-related systemic NHL since it has resulted in a proportion of long-term disease-free survivors.
Collapse
Affiliation(s)
- D A Lowenthal
- Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York
| | | | | | | | | | | |
Collapse
|
43
|
Bernheim A, Berger R. Cytogenetic studies of Burkitt lymphoma-leukemia in patients with acquired immunodeficiency syndrome. CANCER GENETICS AND CYTOGENETICS 1988; 32:67-74. [PMID: 3162708 DOI: 10.1016/0165-4608(88)90313-5] [Citation(s) in RCA: 25] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
The frequency of Burkitt lymphoma-leukemia (BL) is high in patients with acquired immunodeficiency syndrome (AIDS). We describe four such cases, three with a translocation t(8;14)(q24;q32) and one with a t(8;22)(q24;q11). No Epstein-Barr virus genome was found in the tumorous cells of this patient. Including these cases, 13 patients with AIDS-associated BL have been reported so far with specific translocations. Three had a t(8q+; 22q-) variant translocation and the other ten patients had the t(8q-; 14q+). Associated chromosomal abnormalities were as frequent as in ordinary BL and were comparable with those occurring in cases of other BL, such as partial duplication of 1q and 13q34 rearrangements. Trisomy 12, however, was observed in 3 out of 13 AIDS-associated BL cases.
Collapse
Affiliation(s)
- A Bernheim
- Laboratoire de Cytogénétique, Unité INSERM U301, Hôpital St. Louis, Paris, France
| | | |
Collapse
|
44
|
Botti AC, Diamond GR, Verma RS. Lymphoma and acquired immunodeficiency syndrome: cytogenetic and molecular correlates. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY 1988; 24:939-41. [PMID: 3169099 DOI: 10.1016/0277-5379(88)90206-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- A C Botti
- Division of Genetics, Long Island College Hospital, SUNY Health Science Center, Brooklyn 11201
| | | | | |
Collapse
|
45
|
|
46
|
Miller SE, Howell DN. Viral infections in the acquired immunodeficiency syndrome. JOURNAL OF ELECTRON MICROSCOPY TECHNIQUE 1988; 8:41-78. [PMID: 2854554 PMCID: PMC7167188 DOI: 10.1002/jemt.1060080105] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 06/01/1987] [Accepted: 08/14/1987] [Indexed: 01/02/2023]
Abstract
The following communication is a tripartite synopsis of the role of viral infection in the acquired immunodeficiency syndrome (AIDS). The first section describes the impact of viral opportunistic infection in AIDS; for each virus, clinical presentation and diagnosis, laboratory diagnostic approaches (with emphasis on electron microscopy), and therapeutic interventions attempted to date are discussed. The second segment explores current theories on the pathogenesis of AIDS, and describes diagnostic and therapeutic approaches to the syndrome itself. The final section catalogues ultrastructural anomalies in the cells of AIDS patients, many of which have been mistakenly identified as etiologic agents.
Collapse
Affiliation(s)
- S E Miller
- Department of Microbiology, Duke University Medical Center, Durham, North Carolina 27710
| | | |
Collapse
|
47
|
Gill PS, Levine AM. HIV-related malignant lymphoma: clinical aspects, treatment, and pathogenesis. Cancer Invest 1988; 6:413-6. [PMID: 3179773 DOI: 10.3109/07357908809080070] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- P S Gill
- Division of Hematology, University of Southern California School of Medicine, Los Angeles
| | | |
Collapse
|
48
|
Kosmo MA, Mitsuyasu RT, Sparkes RS, Gale RP. Trisomy 12 in Burkitt-like lymphoma associated with acquired immunodeficiency syndrome. CANCER GENETICS AND CYTOGENETICS 1987; 29:245-51. [PMID: 3677046 DOI: 10.1016/0165-4608(87)90235-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Cytogenetic abnormalities have been reported in lymphoproliferative disorders, the most common of which is the t(8;14) translocation in Burkitt and Burkitt-like lymphomas. We report a 30-year-old homosexual male with Burkitt-like lymphoma and trisomy 12. This patient presented with persistent generalized lymphadenopathy and subsequently developed advanced lymphoma. Cell surface markers revealed a monoclonal pattern containing mu heavy chain and kappa light chain immunoglobulins. Cytogenetic analysis of bone marrow involved with lymphoma revealed an additional chromosome #12. Mitogen-stimulated cultures of peripheral blood showed a normal 46,XY karyotype. Trisomy 12 has been found in chronic lymphocytic leukemia and in other low-grade B-cell lymphoproliferative disorders, but not in Burkitt-like lymphoma.
Collapse
Affiliation(s)
- M A Kosmo
- Department of Medicine, UCLA School of Medicine 90024
| | | | | | | |
Collapse
|
49
|
Parrinello AE, Legnami FA, Fiorilli M, Zecchinato F, Papetti C, Aiuti F. Case Report of a Burkitt-Like Lymphoma in a Bisexual Hiv-Positive Man. TUMORI JOURNAL 1987; 73:397-401. [PMID: 3660478 DOI: 10.1177/030089168707300413] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The clinical and pathologic features of a Burkitt-like lymphoma in a bisexual HIV-seropositive man are reported. Emphasis is placed on some histologic characteristics present in a hyperplastic lymph node removed 2 years before the development of the B-cell lymphoma.
Collapse
Affiliation(s)
- A E Parrinello
- Department of Medicine, Legnago General Hospital, Verona, Italia
| | | | | | | | | | | |
Collapse
|
50
|
Abstract
Aside from opportunistic infections, several neoplasms have been identified as part of the spectrum of acquired immunodeficiency syndrome (AIDS) as defined by the Centers for Disease Control. Kaposi's sarcoma (KS) was the first such neoplasm to be recognized within the spectrum of AIDS. Although the classic form of Kaposi's sarcoma had been well recognized prior to the epidemic of AIDS, it was quite distinct from the illness that was seen in its "epidemic" form in young homosexual males. In this setting, Kaposi's sarcoma is an aggressive disease, with extensive involvement of skin and mucous membranes, early dissemination to lymph nodes, impressive development of extreme lymphedema, even in the absence of bulky adenopathy, and rapid spread to visceral organs, including lungs and gastrointestinal tract, among others. Although rapid clinical progression and short median survival have been the rule, a spectrum of disease has been seen such that some patients have survived for many years with disease limited to the skin. Certain clinical and laboratory features, such as presence of unexplained fever, night sweats, weight loss ("B" symptoms), or significant T-4-lymphocytopenia, have been identified as indicators of poor prognosis. Various therapeutic interventions have been employed in epidemic KS, and although partial and complete remissions have occurred, no regimen yet reported has significantly improved the survival of treated patients. High-dose recombinant alpha interferon has produced response rates in approximately 30% of treated patients, although toxicity has been observed in approximately 30% as well. Likewise, vinblastine has produced similar response rates with no evidence of long-term efficacy or "cure." Aside from Kaposi's sarcoma, lymphoma primary to the central nervous system was recognized early in the AIDS epidemic as a criterion for inclusion within AIDS in patients less than sixty years of age. Several years after the initial reports of disease, it became apparent that specific types of systemic lymphoma were also quite extraordinary, and the definition of AIDS was amended in June 1985 to include high-grade B-cell lymphomas in individuals who had positive serology or virology for the human immunodeficiency virus (HIV). The AIDS-related lymphomas are characteristic, both pathologically and clinically. The vast majority of these cases have been high-grade B-lymphoid tumors of either immunoblastic or small-non-cleaved type (also known as "undifferentiated," Burkitt, or Burkitt-like).(ABSTRACT TRUNCATED AT 400 WORDS)
Collapse
|